
Conference Coverage
Latest News

Belatamab Mafodotin Triplet Improved Survival, Responses in Patients Refractory to Lenalidomide

Teen Angst, Adolescent Anguish: Could It Be Mental Illness?

FDA Grants Accelerated Approval to Elamipretide, First Treatment for Barth Syndrome

Confronting the Mental Health Crisis: Structural Inequities, Market Pressures, and the Role of Pharmacy Solutions

Subcutaneous Formulation of Guselkumab Receives FDA Approval in Ulcerative Colitis

Shorts








Podcasts
Videos
Continuing Medical Education
All News

FDA Approves Keytruda Qlex Subcutaneous Injection for Adult and Pediatric Patients With Solid Tumors
The approval is supported by findings from the MK-3475A-D77 study.

The Advisory Committee on Immunization Practices (ACIP) voted to recommend that COVID-19 vaccines be administered through individual-based decision making.

Iberdomide enhances chimeric antigen receptor (CAR) T-cell therapy effectiveness in multiple myeloma, boosting immune response and cell functionality.

AI is redefining the workforce by enhancing care and efficiency.

Discover effective strategies for managing eczema, dry skin, sun protection, and acne with expert recommendations for over-the-counter treatments.

A multicenter registry analysis reveals that high-risk cardiovascular patients often miss opportunities to receive pneumococcal and influenza vaccinations, showcasing gaps that could be filled by pharmacists.

Intravenous immunoglobulin (IVIG) treatment significantly reduces infection rates in multiple myeloma patients receiving BCMA bispecific antibodies, showcasing its clinical benefits.

The BMJ study highlights that young children vaccinated against influenza in October experience the greatest protection, with lower infection rates compared to those vaccinated earlier.

Members of the Advisory Committee on Immunization Practices (ACIP) voted to restrict the combined measles, mumps, rubella, and varicella (MMRV) vaccine and hepatitis B vaccine for certain age groups.

With this approval, an effective, nonsteroidal treatment option is available for young patients.

Participating in a pharmacist-led secondary intervention clinic helped achieve large reductions in cholesterol levels among patients who have experienced an acute coronary syndrome

Teclistamab and other bispecific antibodies enhance multiple myeloma treatment but significantly increase infection risks, necessitating proactive management strategies.

Teclistamab shows promising results in newly diagnosed multiple myeloma, enhancing tolerability and achieving high rates of minimal residual disease negativity.

Long-term care pharmacists are significant in lessening the vaccine hesitancy hurdle among facility residents.

Elranatamab combined with daratumumab and lenalidomide shows promising results for treating newly diagnosed multiple myeloma, enhancing patient outcomes.

Pharmacists play a critical role in optimizing triazole therapy in preventing and managing invasive fungal infections.

Fluctuations in glycemic delta, a specific measurement of glucose levels, is an indicator of worsened myocardial infarction outcomes, including greater reductions in left ventricular ejection fraction.

The extensive selection of OTC products for GI problems can be challenging for patients to navigate.

West Coast states unite to enhance vaccine access and guidance for respiratory viruses, prioritizing public health and safety ahead of the 2025-2026 season.

Anti-Amyloid Antibody Treatments, Subcutaneous Formulations, and Improved Symptom Relief Are Offering New Hope for Patients

Enrollment in the Supplemental Nutrition Assistance Program or another food assistance program could help ameliorate food insecurity that contributes to long COVID.

Additionally, the FDA granted a provisional interchangeability designation to both biosimilars.

NCCN updated its small-cell lung cancer guidelines, introducing lurbinectedin for maintenance therapy and removing the chemotherapy-free interval for better treatment strategies.